Cargando…

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

Plasmacytoid dendritic cells (pDCs) specialize in the secretion of type I interferons (IFN-I) and thus are considered critical mediators of antiviral responses. We recently reported that pDCs have a very early but limited and transient capacity to curtail viral infections. Additionally, pDC numbers...

Descripción completa

Detalles Bibliográficos
Autores principales: Swiecki, Melissa, Wang, Yaming, Vermi, William, Gilfillan, Susan, Schreiber, Robert D., Colonna, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256963/
https://www.ncbi.nlm.nih.gov/pubmed/22084408
http://dx.doi.org/10.1084/jem.20110654
_version_ 1782221082698186752
author Swiecki, Melissa
Wang, Yaming
Vermi, William
Gilfillan, Susan
Schreiber, Robert D.
Colonna, Marco
author_facet Swiecki, Melissa
Wang, Yaming
Vermi, William
Gilfillan, Susan
Schreiber, Robert D.
Colonna, Marco
author_sort Swiecki, Melissa
collection PubMed
description Plasmacytoid dendritic cells (pDCs) specialize in the secretion of type I interferons (IFN-I) and thus are considered critical mediators of antiviral responses. We recently reported that pDCs have a very early but limited and transient capacity to curtail viral infections. Additionally, pDC numbers are not sustained in human infections caused by Hepatitis B or C viruses (HBV and HCV) and HIV. Thus, the numbers and/or function of pDCs appear to be regulated during the course of viral infection. In this study, we show that splenic pDCs are reduced in vivo during several systemic viral infections and after administration of synthetic toll-like receptor ligands. We demonstrate that IFN-I, regardless of the source, contributes to this decline and mediates pDC death via the intrinsic apoptosis pathway. These findings demonstrate a feedback control mechanism by which IFN-I modulates pDC numbers, thus fine-tuning systemic IFN-I response to viruses. IFN-I–mediated control of pDCs may explain the loss of pDCs during human infections caused by HBV, HCV, or HIV and has important therapeutic implications for settings in which IFN-I is used to treat infections and autoimmune diseases.
format Online
Article
Text
id pubmed-3256963
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-32569632012-05-21 Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo Swiecki, Melissa Wang, Yaming Vermi, William Gilfillan, Susan Schreiber, Robert D. Colonna, Marco J Exp Med Brief Definitive Report Plasmacytoid dendritic cells (pDCs) specialize in the secretion of type I interferons (IFN-I) and thus are considered critical mediators of antiviral responses. We recently reported that pDCs have a very early but limited and transient capacity to curtail viral infections. Additionally, pDC numbers are not sustained in human infections caused by Hepatitis B or C viruses (HBV and HCV) and HIV. Thus, the numbers and/or function of pDCs appear to be regulated during the course of viral infection. In this study, we show that splenic pDCs are reduced in vivo during several systemic viral infections and after administration of synthetic toll-like receptor ligands. We demonstrate that IFN-I, regardless of the source, contributes to this decline and mediates pDC death via the intrinsic apoptosis pathway. These findings demonstrate a feedback control mechanism by which IFN-I modulates pDC numbers, thus fine-tuning systemic IFN-I response to viruses. IFN-I–mediated control of pDCs may explain the loss of pDCs during human infections caused by HBV, HCV, or HIV and has important therapeutic implications for settings in which IFN-I is used to treat infections and autoimmune diseases. The Rockefeller University Press 2011-11-21 /pmc/articles/PMC3256963/ /pubmed/22084408 http://dx.doi.org/10.1084/jem.20110654 Text en © 2011 Swiecki et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Brief Definitive Report
Swiecki, Melissa
Wang, Yaming
Vermi, William
Gilfillan, Susan
Schreiber, Robert D.
Colonna, Marco
Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
title Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
title_full Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
title_fullStr Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
title_full_unstemmed Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
title_short Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
title_sort type i interferon negatively controls plasmacytoid dendritic cell numbers in vivo
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256963/
https://www.ncbi.nlm.nih.gov/pubmed/22084408
http://dx.doi.org/10.1084/jem.20110654
work_keys_str_mv AT swieckimelissa typeiinterferonnegativelycontrolsplasmacytoiddendriticcellnumbersinvivo
AT wangyaming typeiinterferonnegativelycontrolsplasmacytoiddendriticcellnumbersinvivo
AT vermiwilliam typeiinterferonnegativelycontrolsplasmacytoiddendriticcellnumbersinvivo
AT gilfillansusan typeiinterferonnegativelycontrolsplasmacytoiddendriticcellnumbersinvivo
AT schreiberrobertd typeiinterferonnegativelycontrolsplasmacytoiddendriticcellnumbersinvivo
AT colonnamarco typeiinterferonnegativelycontrolsplasmacytoiddendriticcellnumbersinvivo